TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004
TCL Archive Biggest NCI Budget Brings Large Headache: More Commitments, Rising Costs, Opportunities December 8, 1989
TCL Archive In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed April 6, 1984
